LUMC to Fund New Clinical Trial of Cynata’s Cymerus™ MSCs in Kidney Transplantation

Cynata Therapeutics Limited announced that the Leiden University Medical Center (LUMC) is funding an important clinical trial to investigate Cynata’s Cymerus™ MSCs as a treatment for renal graft rejection and to potentially reduce the requirement for anti-rejection drugs.